Want to see IN:TORNTPHARM full AI Analyst Report?
Total Valuation
Torrent Pharmaceuticals Ltd has a market cap or net worth of ₹1.94T. The enterprise value is ₹1.65M.
Market Cap₹1.94T
Enterprise Value₹1.65M
Share Statistics
Torrent Pharmaceuticals Ltd has 380,354,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding380,354,250
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Torrent Pharmaceuticals Ltd’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 6.58%.
Return on Equity (ROE)0.26
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.58%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee6.87M
Profits Per Employee1.06M
Employee Count20,341
Asset Turnover0.32
Inventory Turnover2.28
Valuation Ratios
The current PE Ratio of Torrent Pharmaceuticals Ltd is 79.5. Torrent Pharmaceuticals Ltd’s PEG ratio is 5.00.
PE Ratio79.5
PS Ratio10.22
PB Ratio17.02
Price to Fair Value17.02
Price to FCF73.05
Price to Operating Cash Flow161.59
PEG Ratio5.00
Income Statement
In the last 12 months, Torrent Pharmaceuticals Ltd had revenue of 139.80B and earned 21.63B in profits. Earnings per share was 63.92.
Revenue139.80B
Gross Profit68.24B
Operating Income34.62B
Pretax Income28.72B
Net Income21.63B
EBITDA32.57B
Earnings Per Share (EPS)63.92
Cash Flow
In the last 12 months, operating cash flow was 10.38B and capital expenditures -1.96B, giving a free cash flow of 8.42B billion.
Operating Cash Flow10.38B
Free Cash Flow8.42B
Free Cash Flow per Share22.14
Dividends & Yields
Torrent Pharmaceuticals Ltd pays an annual dividend of ₹9, resulting in a dividend yield of 0.29%
Dividend Per Share₹9
Dividend Yield0.29%
Payout Ratio57.65%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change40.22%
50-Day Moving Average4.72K
200-Day Moving Average4.18K
Relative Strength Index (RSI)54.37
Average Volume (3m)7.49K
Important Dates
Torrent Pharmaceuticals Ltd upcoming earnings date is Oct 28, 2026, TBA (Confirmed).
Last Earnings DateJul 30, 2026
Next Earnings DateOct 28, 2026
Ex-Dividend Date―
Financial Position
Torrent Pharmaceuticals Ltd as a current ratio of 1.13, with Debt / Equity ratio of 0.00%
Current Ratio1.13
Quick Ratio0.75
Debt to Market Cap0.10
Net Debt to EBITDA4.27
Interest Coverage Ratio8.99
Taxes
In the past 12 months, Torrent Pharmaceuticals Ltd has paid 7.34B in taxes.
Income Tax7.34B
Effective Tax Rate0.26
Enterprise Valuation
Torrent Pharmaceuticals Ltd EV to EBITDA ratio is 48.11, with an EV/FCF ratio of 80.15.
EV to Sales11.21
EV to EBITDA48.11
EV to Free Cash Flow80.15
EV to Operating Cash Flow59.54
Balance Sheet
Torrent Pharmaceuticals Ltd has ₹23.55B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹23.55B billion.
Cash & Marketable Securities₹23.55B
Total Debt₹0.00
Net Cash₹23.55B
Net Cash Per Share₹61.92
Tangible Book Value Per Share-₹321.20
Margins
Gross margin is 58.00%, with operating margin of 24.76%, and net profit margin of 15.47%.
Gross Margin58.00%
Operating Margin24.76%
Pretax Margin20.54%
Net Profit Margin15.47%
EBITDA Margin23.30%
EBIT Margin23.30%
Analyst Forecast
The average price target for Torrent Pharmaceuticals Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast32.85%
EPS Growth Forecast8.94%